Makoto Onizuka Selected Research

Body Weight (Weight, Body)

1/2022

Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Onizuka Research Topics

Disease

45	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 12/2007
33	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 02/2007
28	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 03/2007
22	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 09/2015
17	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2007
16	Leukemia 10/2023 - 03/2007
14	Neoplasms (Cancer) 01/2024 - 01/2011
11	Philadelphia Chromosome 01/2022 - 11/2010
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 03/2007
7	Bronchiolitis Obliterans Syndrome 01/2024 - 11/2007
7	Lymphoma (Lymphomas) 12/2023 - 01/2011
7	Infections 06/2023 - 01/2011
6	Aplastic Anemia (Anemia, Hypoplastic) 05/2024 - 04/2016
3	Residual Neoplasm 01/2022 - 01/2018
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 07/2017
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2024 - 02/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2023 - 04/2023
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2023 - 09/2014
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2023 - 04/2014
2	Acute Promyelocytic Leukemia 01/2022 - 01/2014
2	Iron Overload 01/2021 - 07/2019
2	Multiple Myeloma 12/2019 - 01/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2011 - 11/2007
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2023
1	Candidemia 04/2023
1	COVID-19 04/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2022
1	Epstein-Barr Virus Infections 01/2022
1	Overweight 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Aspergillosis 12/2021
1	Lung Neoplasms (Lung Cancer) 04/2021
1	Carcinoma (Carcinomatosis) 04/2021
1	Essential Thrombocythemia 04/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021
1	Lung Injury 01/2021

Drug/Important Bio-Agent (IBA)

16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 03/2015
10	HLA Antigens (Human Leukocyte Antigens)IBA 11/2023 - 02/2007
7	Tyrosine Kinase InhibitorsIBA 05/2023 - 09/2017
6	fludarabineIBA 02/2024 - 04/2016
6	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 06/2008
5	Calcineurin InhibitorsIBA 01/2022 - 01/2020
4	Melphalan (Alkeran)FDA LinkGeneric 02/2024 - 01/2019
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 02/2019
4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 06/2015
4	Etoposide (VP 16)FDA LinkGeneric 12/2022 - 03/2015
4	LigandsIBA 01/2022 - 03/2007
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 01/2020
4	KIR ReceptorsIBA 01/2022 - 03/2007
4	AntigensIBA 01/2022 - 03/2008
3	Busulfan (Busulfex)FDA Link 03/2023 - 12/2016
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2024 - 01/2021
2	HLA-DRB1 Chains (HLA DRB1)IBA 10/2023 - 01/2022
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 12/2021
2	HLA-A Antigens (HLA-A)IBA 01/2020 - 02/2015
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2018 - 09/2014
2	Toll-Like Receptor 1IBA 07/2017 - 01/2016
2	ThrombomodulinIBA 10/2015 - 10/2015
2	HLA-DPB1 antigen (HLA DPB1)IBA 02/2015 - 03/2007
2	HLA-C Antigens (HLA-C)IBA 02/2015 - 03/2007
1	Alkylating AgentsIBA 01/2024
1	AnthracyclinesIBA 12/2023
1	venetoclaxIBA 12/2023
1	MannansIBA 04/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023
1	pterostilbeneIBA 01/2022
1	ResveratrolIBA 01/2022
1	PolyphenolsIBA 01/2022
1	A 7 (A-7)IBA 12/2021
1	pembrolizumabIBA 04/2021
1	Immune Checkpoint InhibitorsIBA 04/2021
1	tazemetostatIBA 03/2021
1	indium-bleomycinIBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	NucleosidesIBA 01/2021
1	2-mercaptopurineIBA 01/2021

Therapy/Procedure

47	Cell Transplantation 05/2024 - 04/2016
45	Hematopoietic Stem Cell Transplantation 05/2024 - 03/2008
35	Transplantation 01/2024 - 03/2007
19	Stem Cell Transplantation 03/2024 - 11/2007
16	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 02/2007
12	Therapeutics 12/2023 - 10/2007
8	Homologous Transplantation 02/2024 - 01/2019
8	Drug Therapy (Chemotherapy) 12/2023 - 09/2014
4	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2023 - 09/2015
3	Haploidentical Transplantation 02/2024 - 12/2022
2	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2023 - 01/2021
2	Salvage Therapy 12/2019 - 09/2014
2	Induction Chemotherapy 02/2019 - 01/2019
2	Remission Induction 02/2019 - 01/2019
1	Radiotherapy 10/2023
1	Chemoradiotherapy 10/2023
1	Duration of Therapy 05/2023
1	Oral Administration 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2021